Clinical trial

Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing

NCT02845466

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention Becaplermin Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Promagran Dressing Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Placebo Dressing Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-08-01

PhasePHASE3

Conditions

Venous Ulcerunresolved

Foot Ulcer, Diabeticunresolved

Interventions

BecaplerminBIOLOGICAL

Promagran DressingDEVICE

Placebo DressingDEVICE

Sponsors & collaborators

McMaster Universitylead sponsor

Canadian Institutes of Health Research (CIHR)collaborator

Mapped research locations

HamiltonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02845466 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.